• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弥漫性间质性肺炎。20例接受泼尼松/硫唑嘌呤治疗患者的临床病理相关性

Diffuse interstitial pneumonitis. Clinicopathologic correlations in 20 patients treated with prednisone/azathioprine.

作者信息

Winterbauer R H, Hammar S P, Hallman K O, Hays J E, Pardee N E, Morgan E H, Allen J D, Moores K D, Bush W, Walker J H

出版信息

Am J Med. 1978 Oct;65(4):661-72. doi: 10.1016/0002-9343(78)90855-0.

DOI:10.1016/0002-9343(78)90855-0
PMID:707526
Abstract

Twenty patients with diffuse interstitial pulmonary disease diagnosed by open lung biopsy received combined prednisone/azathioprine therapy. Twelve patients demonstrated improvement with therapy. Each patient's clinical presentation, roentgenologic features and pathologic findings were correlated with their therapeutic response. Patients with an illness of one year's duration or less had a more favorable response to therapy than patients with a greater than two year duration of illness. Patients with associated extrathoracic abnormalities (anemia, glomerulitis, hepatopathy) exhibited a better therapeutic response that those with only pulmonary disease. The biopsy material from each patient was quantitatively graded on 20 morphologic variables. Statistical analysis using multiple linear regression revealed that a single variable, degree of interstitial fibrosis, was more that 90 per cent accurate in separating those responsive to therapy from those who failed to respond. Patients who respond to treatment had less interstitial fibrosis. Neither the amount of alveolar septal inflammation nor intra-alveolar cellular reaction was discriminatory in predicting response to therapy. A beneficial response to therapy was reflected in both improved lung volumes and gas exchange. Eight patients appeared to have a selective beneficial effect from azathioprine.

摘要

20例经开胸肺活检确诊为弥漫性间质性肺疾病的患者接受了泼尼松/硫唑嘌呤联合治疗。12例患者治疗后病情改善。将每位患者的临床表现、放射学特征和病理结果与其治疗反应进行关联分析。病程在1年及以内的患者对治疗的反应比病程超过2年的患者更佳。伴有胸外异常(贫血、肾小球炎、肝病)的患者比仅患有肺部疾病的患者治疗反应更好。对每位患者的活检材料依据20个形态学变量进行定量分级。采用多元线性回归进行统计分析显示,单个变量——间质纤维化程度——在区分治疗反应者与无反应者方面的准确率超过90%。对治疗有反应的患者间质纤维化程度较轻。肺泡间隔炎症的程度和肺泡内细胞反应在预测治疗反应方面均无鉴别意义。治疗的有益反应体现在肺容积和气体交换的改善上。8例患者似乎从硫唑嘌呤治疗中获得了选择性的有益效果。

相似文献

1
Diffuse interstitial pneumonitis. Clinicopathologic correlations in 20 patients treated with prednisone/azathioprine.弥漫性间质性肺炎。20例接受泼尼松/硫唑嘌呤治疗患者的临床病理相关性
Am J Med. 1978 Oct;65(4):661-72. doi: 10.1016/0002-9343(78)90855-0.
2
Interstitial pneumonitis complicating rheumatoid arthritis. Sustained remission with azathioprine therapy.间质性肺炎并发类风湿关节炎。硫唑嘌呤治疗后持续缓解。
Chest. 1977 Oct;72(4):521-4. doi: 10.1378/chest.72.4.521.
3
Bronchiolitis interstitial pneumonitis: a pathologic study of 31 lung biopsies with features intermediate between bronchiolitis obliterans organizing pneumonia and usual interstitial pneumonitis, with clinical correlation.细支气管炎性间质性肺炎:31例肺活检的病理学研究,其特征介于闭塞性细支气管炎并机化性肺炎和普通间质性肺炎之间,并与临床相关。
Ann Diagn Pathol. 2008 Jun;12(3):171-80. doi: 10.1016/j.anndiagpath.2007.07.002. Epub 2007 Oct 24.
4
Fibrosing alveolitis in an infant.婴儿期的纤维化肺泡炎。
Eur Respir J. 1992 Mar;5(3):359-61.
5
Interstitial lung disease resistant to corticosteroid therapy. Report of three cases treated with azathioprine or cyclophosphamide.对皮质类固醇治疗耐药的间质性肺疾病。3例使用硫唑嘌呤或环磷酰胺治疗的报告。
Chest. 1975 Jan;67(1):57-60. doi: 10.1378/chest.67.1.57.
6
Corticosteroid treatment of diffuse interstitial pulmonary fibrosis.弥漫性间质性肺纤维化的皮质类固醇治疗
JAMA. 1970 Jan 19;211(3):495-7.
7
[Therapy of diffuse pulmonary fibrosis (including prevention of development and progression)].弥漫性肺纤维化的治疗(包括预防其发生和进展)
Internist (Berl). 1974 Jul;15(7):386-90.
8
Idiopathic pulmonary fibrosis: predicting response to therapy and survival.特发性肺纤维化:预测治疗反应和生存率
Am J Respir Crit Care Med. 1998 Apr;157(4 Pt 1):1063-72. doi: 10.1164/ajrccm.157.4.9703022.
9
Acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias.特发性肺纤维化(UIP)及其他形式的纤维化间质性肺炎中的急性加重(病因不明的急性肺损伤)
Am J Surg Pathol. 2007 Feb;31(2):277-84. doi: 10.1097/01.pas.0000213341.70852.9d.
10
Management for interstitial lung disease. State of the art.间质性肺疾病的管理。最新进展。
Chest. 1989 Mar;95(3):676-8. doi: 10.1378/chest.95.3.676.

引用本文的文献

1
Desquamative interstitial pneumonia: still orphan and not always benign.脱屑性间质性肺炎:仍然是孤儿,并不总是良性的。
Eur Respir Rev. 2020 Jun 23;29(156). doi: 10.1183/16000617.0183-2020. Print 2020 Jun 30.
2
Diagnostic yield and risk/benefit analysis of trans-bronchial lung cryobiopsy in diffuse parenchymal lung diseases: a large cohort of 699 patients.经支气管肺冷冻活检术在弥漫性实质性肺疾病中的诊断率和风险/效益分析:一项 699 例患者的大样本队列研究。
BMC Pulm Med. 2019 Jan 16;19(1):16. doi: 10.1186/s12890-019-0780-3.
3
Adherence to guidelines in idiopathic pulmonary fibrosis: a follow-up national survey.
特发性肺纤维化指南的依从性:一项全国性随访调查。
ERJ Open Res. 2015 Nov 16;1(2). doi: 10.1183/23120541.00032-2015. eCollection 2015 Oct.
4
Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines.特发性肺纤维化的诊断与管理:法国实用指南
Eur Respir Rev. 2014 Jun;23(132):193-214. doi: 10.1183/09059180.00001814.
5
Systemic sclerosis: comparison of efficacy of oral cyclophosphamide and azathioprine on skin score and pulmonary involvement-a retrospective study.系统性硬化症:口服环磷酰胺与硫唑嘌呤对皮肤评分及肺部受累疗效的比较——一项回顾性研究
Rheumatol Int. 2014 Dec;34(12):1691-9. doi: 10.1007/s00296-014-3026-y. Epub 2014 May 7.
6
A review of current and novel therapies for idiopathic pulmonary fibrosis.特发性肺纤维化的现有和新型治疗方法综述。
J Thorac Dis. 2013 Feb;5(1):48-73. doi: 10.3978/j.issn.2072-1439.2012.12.07.
7
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.特发性肺纤维化:诊断和管理的循证指南(美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会联合发布)
Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824. doi: 10.1164/rccm.2009-040GL.
8
Thiopurine S- methyltransferase [corrected] testing in idiopathic pulmonary fibrosis: a pharmacogenetic cost-effectiveness analysis.特发性肺纤维化中硫嘌呤 S- 甲基转移酶[校正]检测:药物遗传学成本效益分析。
Lung. 2010 Apr;188(2):125-32. doi: 10.1007/s00408-009-9217-8.
9
Comparison of clinicoradiologic manifestation of nonspecific interstitial pneumonia and usual interstitial pneumonia/idiopathic pulmonary fibrosis: a report from NRITLD.非特异性间质性肺炎与普通间质性肺炎/特发性肺纤维化的临床影像学表现比较:NRITLD 研究报告。
Ann Thorac Med. 2008 Oct;3(4):140-5. doi: 10.4103/1817-1737.43081.
10
Idiopathic interstitial pneumonias: progress in classification, diagnosis, pathogenesis and management.特发性间质性肺炎:分类、诊断、发病机制及治疗进展
Trans Am Clin Climatol Assoc. 2004;115:43-76; discussion 76-8.